According to CMS data, Medicare Part D spending ... of Medicare negotiations yielded discounts on drugs ranging from 40 percent to 80 percent, including 76 percent off the list price for NovoLog.

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process of negotiating prices for certain Medicare Part D drugs with input ...

CMS said it will announce maximum fair ... Human Services on the selection of 15 additional drugs under Medicare Part D for price negotiations. We are increasingly concerned about the impact ...

In 2022, the U.S. Congress passed the Inflation Reduction Act, which gave Medicare the authority to negotiate certain prescription drug prices ... D. In August 2023, the Centers for Medicare and ...

Soon, the Centers for Medicare and Medicaid Services will begin the price negotiation process on a new ... some of which (like R&D costs) have nothing to do with value while others (like clinical ...

Americans pay disproportionately to subsidize pharmaceutical innovation, while the rest of the world benefits and pays less ...

The Centers for Medicare & Medicaid Services recently began meeting with patients who use the 15 drugs it selected for the ...

Medicare drug price negotiation is still relatively new. Until the 2022 passage of the Inflation Reduction Act, Medicare part D, which covers more than 50 ... On May 12, the Centers for Medicare and ...